Clinical Trials Browser

Not yet recruiting × Bendamustine Hydrochloride × Lymphoid × Clear all

NCT07225985 2026-03-06

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Phase 1/2 Not yet recruiting

Lymphoma, T-Cell

NCT07259122 2025-12-02

ZBR in WM

Phase 2 Not yet recruiting

Waldenstrom Macroglobulinemia

NCT07206264 2025-10-03

ADAPT-MCL

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, Mantle-Cell

NCT07169565 2025-09-11

Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia

Phase 1 Not yet recruiting

Waldenstrom Macroglobulinemia

NCT07003464 2025-06-04

Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06942507 2025-04-30

BRZ-WM

Phase NA Not yet recruiting

Waldenstrom Macroglobulinemia

NCT06761911 2025-01-07

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

Phase 4 Not yet recruiting

Hodgkin Disease, Recurrence

NCT06557330 2025-01-06

MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma

Phase 2 Not yet recruiting

Lymphoma

NCT06757894 2025-01-03

Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma

Phase 2 Not yet recruiting

Lymphoma, Follicular

NCT04913103 2021-06-04

CLSGMCLPOLA

Phase 2 Not yet recruiting

Lymphoma, Mantle-Cell